Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: A 15-year experience

Transplant Infectious Disease

Volumn 10, Issue 3, 2008, Pages 177-183

  Crassard, N ^a,b   Hadden, H ^b   Pondarre C ^b   Hadden, R ^c   Galambrun, C ^b   Piens, M A ^d   Pracros, J P ^b   Souillet, G ^b   Basset, T ^b   Berthier, J C ^b   Philippe, N ^b   Bertrand, Y ^b  

^a Centre Hospitalier Fleyriat   (France)

^b HÔPITAL DEBROUSSE   (France)

^c UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

Hematopoietic stem cell transplantation; Invasive aspergillosis; Pediatrics

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CASPOFUNGIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUCYTOSINE; ITRACONAZOLE; MELPHALAN; METHOTREXATE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HIGH RISK PATIENT; HUMAN; HURLER SYNDROME; IMMUNE DEFICIENCY; INCIDENCE; INFANT; LUNG; LUNG INSUFFICIENCY; LUNG LAVAGE; MEDICAL RECORD REVIEW; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS INFECTION;

ADOLESCENT; ASPERGILLOSIS; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 43949133881     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00304.x     Document Type: Article

References (28)

1. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990 12 : 1147 1201 [published erratum appears in Rev Infect Dis 1991; 13(2): 345].
2. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001 32 : 358 366.
3. Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001 33 : 41 47.
4. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002 51 : 288 296.
5. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002 100 : 4358 4366.
6. Grow WB, Moreb JS, Roque D, et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 2002 29 : 15 19.
7. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Microbiol Infect Dis 2002 21 : 161 172.
8. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 : 7 14.
9. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997 175 : 1459 1466.
10. Ribaud P, Chastang C, Latge JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999 28 : 322 330.
11. Thursky K, Byrnes G, Grigg A, Szer J, Slavin M. Risk factor for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplant 2004 34 : 115 121.
12. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001 32 : 1319 1324.
13. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999 29 : 1210 1219.
14. Castagnola E, Machetti M, Bucci B, Viscoli C. Antifungal prophylaxis with azole derivatives. Clin Microbiol Infect 2004 10 (Suppl 1) : 86 95.
15. Glasmacher A, Prentice A, Gorschluter M, et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. J Clin Oncol 2003 21 : 4615 4626.
16. Winston DJ, Maziarz RT, Chandrasekar PH, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 2003 138 : 705 713.
17. Marr KA, Crippa F, Leisenring W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004 103 : 1527 1533.
18. Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998 26 : 1098 1103.
19. Fukuda T, Boeckh M, Guthrie KA, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-years experience at a single transplant center. Biol Blood Marrow Transplant 2004 10 : 494 503.
20. Richard C, Romon I, Baro J, et al. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 1993 12 : 237 241.
21. Nosari A, Oreste P, Cairoli R, et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001 68 : 231 236.
22. Avivi I, Oren I, Haddad N, Rowe JM, Dann EJ. Stem cell transplantation post invasive fungal infection is a feasible task. Am J Hematol 2004 75 : 6 11.
23. Hoover M, Morgan ER, Kletzel M. Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol 1997 28 : 268 273.
24. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997 15 : 139 147.
25. Gow KW, Hayes-Jordan AA, Billups CA, et al. Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes. J Pediatr Surg 2003 38 : 1354 1360.
26. Cordonnier C, Beaune J, Offner F, et al. Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group. Bone Marrow Transplant 1995 16 : 323 324.
27. Cordonnier C, Maury S, Pautas C, et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant 2004 33 : 943 948.
28. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004 39 : 743 746.